INSULET CORP
PODDNasdaq · SIC 3841
$164.06
↓ -0.2%Jul 17 close · end-of-day
Price
1Y↓ -43.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$11.5B
Enterprise Value
$12.5B
P/E
38.3
P/S
4.0
P/B
8.8
EV/EBITDA
20.7
PEG
0.1
FCF Yield
3.6%
Dividend Yield
—
Revenue (TTM)
$2.9B
Net Income (TTM)
$302.8M
Free Cash Flow (TTM)
$415.7M
Gross Margin
71.0%
Operating Margin
17.5%
Net Margin
10.4%
ROE
23.3%
ROIC
16.9%
Debt / Equity
0.7
Net Cash
-$948.1M
Return 1Y
-42.1%
Company profile
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless device that is worn on the body for up to three days at a time. The company sells its products primarily through independent distributors and pharmacy channels.
- CEO
- James R. Hollingshead
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 2,600
- Headquarters
- Massachusetts
- Website
- insulet.com
Management & directors
- Mcevoy AshleyPresident and CEO
- Panos MichaelEVP and CCO
- Benjamin EricEVP and COO
- Budden LaurenGroup VP, CAO and Controller
- Cousin LaetitiaSVP, Reg, Quality & Compliance
- Kapples John W.SVP and General Counsel
- Singh PremSVP, Global Operations
- Davis Lisa BlairSVP, Chief HR Officer
- Pease FlaviaEVP & CFO
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-08-05
PODD Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$761.7M↑ +33.9%
Diluted EPS$1.30↑ +160.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $904.4M | $1.1B | $1.3B | $1.7B | $2.1B | $2.7B |
| Gross profit | $582.3M | $752.1M | $805.6M | $1.2B | $1.4B | $1.9B |
| Operating income | $51.5M | $126.0M | $37.6M | $220.1M | $308.9M | $473.8M |
| Net income | $6.8M | $16.8M | $4.6M | $206.3M | $418.3M | $247.1M |
| Diluted EPS | $0.10 | $0.24 | $0.07 | $2.94 | $5.78 | $3.48 |
| Operating cash flow | $84.0M | -$68.1M | $119.0M | $145.7M | $430.2M | $569.3M |
| Free cash flow | -$45.0M | -$180.0M | -$3.9M | $70.1M | $305.3M | $377.7M |
| Gross margin | 64.4% | 68.4% | 61.7% | 68.3% | 69.8% | 71.6% |
| Operating margin | 5.7% | 11.5% | 2.9% | 13.0% | 14.9% | 17.5% |
| Net margin | 0.8% | 1.5% | 0.4% | 12.2% | 20.2% | 9.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $488.5M | $543.9M | $597.5M | $569.0M | $649.1M | $706.3M | $783.7M | $761.7M |
| Gross profit | $330.9M | $377.1M | $430.9M | $409.0M | $452.2M | $510.1M | $568.6M | $529.1M |
| Operating income | $54.5M | $88.1M | $109.4M | $88.8M | $121.1M | $117.7M | $146.2M | $122.1M |
| Net income | $188.6M | $77.5M | $100.7M | $35.4M | $22.5M | $87.6M | $101.6M | $91.1M |
| Diluted EPS | $2.59 | $1.08 | $1.38 | $0.50 | $0.32 | $1.24 | $1.42 | $1.30 |
| Operating cash flow | $86.8M | $108.3M | $147.5M | $63.8M | $196.5M | $125.7M | $183.3M | $113.8M |
| Free cash flow | $64.3M | $81.6M | $93.9M | $51.5M | $177.9M | $100.1M | $48.2M | $89.5M |
| Gross margin | 67.7% | 69.3% | 72.1% | 71.9% | 69.7% | 72.2% | 72.6% | 69.5% |
| Operating margin | 11.2% | 16.2% | 18.3% | 15.6% | 18.7% | 16.7% | 18.7% | 16.0% |
| Net margin | 38.6% | 14.2% | 16.9% | 6.2% | 3.5% | 12.4% | 13.0% | 12.0% |
Company news
Jul 20, 2026
Jul 14, 2026
- 6d agoInsulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Mossfinance.yahoo.com
- 6d agoGlobal Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insightsfinance.yahoo.com
Jul 13, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | MAZELSKY JONATHAN JAY | Award | 1,355 | $0.00 | $0.00 | filing |
| 2026-06-30 | Huffines Robert Luther | Award | 144 | $159.79 | $23,009.76 | filing |
| 2026-06-30 | Huffines Robert Luther | Award | 151 | $152.25 | $22,989.75 | filing |
| 2026-06-03 | WEATHERMAN ELIZABETH H | Buy | 3,450 | $144.20 | $497,490.00 | filing |
| 2026-06-03 | STONESIFER TIMOTHY C. | Buy | 2,790 | $143.51 | $400,392.90 | filing |
| 2026-06-03 | BORIO LUCIANA | Sale | 418 | $143.27 | $59,886.86 | filing |
| 2026-05-20 | Hopfield Jessica | Award | 1,660 | $0.00 | $0.00 | filing |
| 2026-05-20 | Frederick Wayne A.I. | Award | 1,660 | $0.00 | $0.00 | filing |
| 2026-05-20 | BORIO LUCIANA | Award | 1,660 | $0.00 | $0.00 | filing |
| 2026-05-20 | WEATHERMAN ELIZABETH H | Award | 1,660 | $0.00 | $0.00 | filing |
| 2026-05-20 | STONESIFER TIMOTHY C. | Award | 1,660 | $0.00 | $0.00 | filing |
| 2026-05-20 | Scannell Timothy J | Award | 1,660 | $0.00 | $0.00 | filing |
| 2026-05-20 | MINOGUE MICHAEL R | Award | 1,660 | $0.00 | $0.00 | filing |
| 2026-05-20 | Huffines Robert Luther | Award | 1,660 | $0.00 | $0.00 | filing |
| 2026-05-13 | McEvoy Ashley· President and CEO | Tax withholding | 1,411 | $148.84 | $210,013.24 | filing |
| 2026-04-01 | Panos Michael· EVP and CCO | Award | 2,777 | $0.00 | $0.00 | filing |
| 2026-03-31 | Huffines Robert Luther | Award | 111 | $209.84 | $23,292.24 | filing |
| 2026-02-27 | Benjamin Eric· EVP and COO | Tax withholding | 644 | $246.61 | $158,816.84 | filing |
| 2026-02-27 | Kapples John W.· SVP and General Counsel | Tax withholding | 411 | $246.61 | $101,356.71 | filing |
| 2026-02-27 | Benjamin Eric· EVP and COO | Tax withholding | 268 | $246.61 | $66,091.48 | filing |
| 2026-02-27 | Singh Prem· SVP, Global Operations | Tax withholding | 207 | $246.61 | $51,048.27 | filing |
| 2026-02-27 | Cousin Laetitia· SVP, Reg, Quality & Compliance | Tax withholding | 200 | $246.61 | $49,322.00 | filing |
| 2026-02-27 | Kapples John W.· SVP and General Counsel | Tax withholding | 194 | $246.61 | $47,842.34 | filing |
| 2026-02-27 | Budden Lauren· Group VP, CAO and Controller | Tax withholding | 119 | $246.61 | $29,346.59 | filing |
| 2026-02-27 | Budden Lauren· Group VP, CAO and Controller | Tax withholding | 99 | $246.61 | $24,414.39 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.